Safety and tumour hypoxia modifying effect of buparlisib with radiotherapy in NSCLC: a phase I dose escalation study
McGowan DR., Skwarski M., Bradley KM., Fenwick JD., Gleeson FV., Horne A., Maughan T., McKenna WG., Mohammed S., Muschel RJ., Ng SM., Panakis N., Strauss VY., Stuart R., Vallis KA., Macpherson RE., Higgins GS.